Bruker
BRKR
311 hedge funds and large institutions have $6.83B invested in Bruker in 2022 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 104 increasing their positions, 119 reducing their positions, and 52 closing their positions.
69% more call options, than puts
Call options by funds: $7.12M | Put options by funds: $4.21M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.5% less ownership
Funds ownership: 70.93% → 70.44% (-0.5%)
5% less funds holding
Funds holding: 327 → 311 (-16)
13% less repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 119
24% less capital invested
Capital invested by funds: $8.98B → $6.83B (-$2.15B)
27% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 52
Top Buyers
Top Sellers
BRKR Hedge Fund Activity: Q1 2022 in Review
311 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bruker (BRKR) for Q1 2022, worth a combined $6.83B — down 24% from $8.98B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of BRKR and 38 opened new positions — a net loss of 14 holders — while 119 trimmed existing stakes and 104 added.
The largest buyer was Massachusetts Financial Services, adding an estimated $122M. The largest seller was Fidelity Investments, cutting an estimated $118M.
- 311 institutional investors held Bruker (BRKR) as of Q1 2022, down from 327 in Q4 2021.
- Funds reported $6.83B of Bruker stock for Q1 2022, down 24% quarter-over-quarter.
- 38 funds opened new Bruker positions in Q1 2022 and 52 closed out, a net change of -14 holders.
- The largest Bruker buyer in Q1 2022 was Massachusetts Financial Services, an estimated $122M added.
- The largest Bruker seller in Q1 2022 was Fidelity Investments, an estimated $118M sold.
Based on aggregated 13F filings for Q1 2022.